Romedahl MedScience ApS: Financial statements 2020
CVR: 38540580
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Romedahl MedScience ApS (CVR 38540580) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -8,933 compared with DKK 0 the year before. Equity in the 2020 report amounted to DKK -5,433. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -8,933
- Equity
- DKK -5,433
- Total Assets
- DKK 29,393
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | - | -9 t. | -5 t. | 1 |
| 2019 | - | 0 | 0 | 4 t. | 0 |
| 2018 | 0 | 0 | 0 | 4 t. | - |
Official annual report
How creditworthy is Romedahl MedScience ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Romedahl MedScience ApS has published its annual report for 2019. Gross profit came to DKK 0, and the net result was DKK 0.
About Romedahl MedScience ApS
Romedahl MedScience ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Romedahl MedScience IVS. The management consists of Hanne Risager Romedahl. The company is owned by Hanne Risager Romedahl. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -8,552 compared with DKK -6,398 the year before. Equity in the 2025 report amounted to DKK 642.